Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Survival strategies of infectious biofilms.

Fux CA, Costerton JW, Stewart PS, Stoodley P.

Trends Microbiol. 2005 Jan;13(1):34-40. Review.

PMID:
15639630
2.

Depolymerization of beta-1,6-N-acetyl-D-glucosamine disrupts the integrity of diverse bacterial biofilms.

Itoh Y, Wang X, Hinnebusch BJ, Preston JF 3rd, Romeo T.

J Bacteriol. 2005 Jan;187(1):382-7.

3.

Viridans streptococci in endocarditis and neutropenic sepsis: biofilm formation and effects of antibiotics.

Presterl E, Grisold AJ, Reichmann S, Hirschl AM, Georgopoulos A, Graninger W.

J Antimicrob Chemother. 2005 Jan;55(1):45-50. Epub 2004 Nov 24.

PMID:
15563519
4.

Understanding biofilm resistance to antibacterial agents.

Davies D.

Nat Rev Drug Discov. 2003 Feb;2(2):114-22. Review. No abstract available.

PMID:
12563302
5.

Biofilms as complex differentiated communities.

Stoodley P, Sauer K, Davies DG, Costerton JW.

Annu Rev Microbiol. 2002;56:187-209. Epub 2002 Jan 30. Review.

PMID:
12142477
6.

Synthesis and antimicrobial activities of N-substituted imides.

Zentz F, Valla A, Le Guillou R, Labia R, Mathot AG, Sirot D.

Farmaco. 2002 May;57(5):421-6.

PMID:
12058815
7.

Biofilm formation and dispersal under the influence of the global regulator CsrA of Escherichia coli.

Jackson DW, Suzuki K, Oakford L, Simecka JW, Hart ME, Romeo T.

J Bacteriol. 2002 Jan;184(1):290-301.

8.

Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance.

Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA.

J Bacteriol. 2001 Sep;183(18):5385-94.

9.

Activities of bismuth thiols against staphylococci and staphylococcal biofilms.

Domenico P, Baldassarri L, Schoch PE, Kaehler K, Sasatsu M, Cunha BA.

Antimicrob Agents Chemother. 2001 May;45(5):1417-21.

10.

Biofilms and device-associated infections.

Donlan RM.

Emerg Infect Dis. 2001 Mar-Apr;7(2):277-81. Review.

11.

Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin.

Anderl JN, Franklin MJ, Stewart PS.

Antimicrob Agents Chemother. 2000 Jul;44(7):1818-24.

12.

Effects of hydrogel/silver coatings on in vitro adhesion to catheters of bacteria associated with urinary tract infections.

Ahearn DG, Grace DT, Jennings MJ, Borazjani RN, Boles KJ, Rose LJ, Simmons RB, Ahanotu EN.

Curr Microbiol. 2000 Aug;41(2):120-5.

PMID:
10856378
14.

Bacterial biofilms: a common cause of persistent infections.

Costerton JW, Stewart PS, Greenberg EP.

Science. 1999 May 21;284(5418):1318-22. Review.

PMID:
10334980
15.

A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group.

Darouiche RO, Raad II, Heard SO, Thornby JI, Wenker OC, Gabrielli A, Berg J, Khardori N, Hanna H, Hachem R, Harris RL, Mayhall G.

N Engl J Med. 1999 Jan 7;340(1):1-8.

17.

A simple artificial urine for the growth of urinary pathogens.

Brooks T, Keevil CW.

Lett Appl Microbiol. 1997 Mar;24(3):203-6.

18.

Activity of a nitrofurazone matrix urinary catheter against catheter-associated uropathogens.

Johnson JR, Berggren T, Conway AJ.

Antimicrob Agents Chemother. 1993 Sep;37(9):2033-6.

19.

Protamine sulfate and vancomycin are synergistic against Staphylococcus epidermidis prosthesis infection in vivo.

Teichman JM, Abraham VE, Stein PC, Parsons CL.

J Urol. 1994 Jul;152(1):213-6.

PMID:
8201668

Supplemental Content

Support Center